PS Ratio: 1.08

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 1.08 is 98% below its estimated 5-year average of 59.14, near the low end of its estimated 5-year range (1.08–6274.95).

As of 2026-10-06T16:10:36.062Z. 95.26% below its estimated 12-month average of 22.78.

ALGS PS Ratio Metrics

P/S vs. estimated history

At 1.08, P/S is below its estimated 5-year median — higher than 0% of readings in its estimated 5-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Aligos Therapeutics, Inc. (ALGS)?

The P/S ratio for ALGS stock is 1.08.

Is Aligos Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 1.08 is 98% below its estimated 5-year average of 59.14, near the low end of its estimated 5-year range (1.08–6274.95).

What is the estimated TTM average P/S ratio for Aligos Therapeutics, Inc. (ALGS)?

The estimated TTM average P/S ratio for ALGS stock is 22.78.

What is the estimated 3Y average P/S ratio for Aligos Therapeutics, Inc. (ALGS)?

The estimated 3Y average P/S ratio for ALGS stock is 25.19.

What is the estimated 5Y average P/S ratio for Aligos Therapeutics, Inc. (ALGS)?

The estimated 5Y average P/S ratio for ALGS stock is 59.14.

Showing the most recent 260 of 1,357 data points. The chart above shows the full history.

Related Metrics